California Supreme Court To Review $500M Judgment Vs. Genentech

Law360, New York (February 3, 2005, 12:00 AM EST) -- California’s Supreme Court has agreed to review a judgment by an appeals court that ordered biotech company Genentech to pay $500 million, including $200 million in punitive damages, for failing to pay licensing fees to a Southern California medical research center.

In October, the 2nd District Court of Appeal upheld more than $500 million in damages against Genentech in a dispute over royalties on human insulin and human growth hormone developed in part by the City of Hope National Medical Center.

The appeals court ruled unanimously...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.